Central Laboratories White Papers & Articles

31. Enhancing Clinical Trials With CliniPilot And Clear To Clinic Programme 8/20/2026

    See how connected drug delivery solutions help accelerate study execution, improve data quality, support decentralized trials, and boost patient engagement with ready-to-use platforms.

32. Five Integration Pillars To Redefine Frontline Patient Engagement And Safety Operations 8/20/2026

    Siloed medical information, patient support, product quality, and pharmacovigilance functions, alongside increasing biopharmaceutical complexity, require a unified operating model to meet modern demand.

33. The State Of The Clinical Development Race 8/14/2026

    Every medicine reaching a patient has run a race from a crowded grid of candidates through the clinical development circuit to the market launch podium. Catch up on what’s in store for this season.

34. Examining The New Look For Biotech 8/14/2026

    According to a recent episode of Citeline’s podcast series, “Small Biotechs, Big Decisions,” biotech is developing a new look that is leaner and savvier when it comes to working with partners.

35. How AI Is Revolutionizing Clinical Development 8/14/2026

    Artificial intelligence is expanding from the preclinical phase of clinical trials into Phases I–III, where is it being used in protocol design, site selection, feasibility, and patient recruitment.

36. Matching Pharmacovigilance Methodology To Organizational Scale 8/12/2026

    One-size-fits-all doesn't work for safety signal detection. Discover a scalable framework that keeps expert judgment at the center — no matter how large your portfolio grows.

37. AI Tools In Informed Consent: What Sponsors Need To Know About Risk 8/1/2026

    AI tools carry different risks. See how they can impact participant communications, where bias and inaccuracies emerge, and why human review is critical to protecting study integrity.

38. From Data Delays To Decision Speed 7/31/2026

    The biggest risk in modern trials isn’t missing data. It’s delayed insight. Discover how real-time intelligence helps teams act faster, reduce risk, and improve trial execution.

39. Why Legacy RTSM Systems Create Risk in Biosimilar Trials 7/31/2026

    Learn how real-time visibility, adaptive supply planning, and proactive risk management can reduce waste and improve study execution.

40. The FDA Just Rewrote The Rules For Clinical Trials. Here's What It Means For RTSM. 7/30/2026

    Learn how evolving trial designs are changing RTSM requirements and driving demand for greater flexibility, traceability, and execution quality.